Pertussis hospitalizations in France (2008–2020): A real-world retrospective analysis of incidence and costs based on the French National Health Data System
Background: Assessing pertussis burden and the impact of the 2013 vaccination schedule update (3 + 1 to 2 + 1 schedule) in France is hindered by non-mandatory reporting. We aimed to estimate the cumulative incidence and hospitalization costs due to pertussis in France between 2008 and 2020. Methods:...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-08-01
|
| Series: | Journal of Infection and Public Health |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034125001509 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849421122139848704 |
|---|---|
| author | Juan C. Vargas-Zambrano Mickael Arnaud Ana Antunes Khalil Karzazi Johanna Despres Regis Verdier Florence Boisnard Jerome Jund Cecile Janssen Didier Pinquier Denis Macina |
| author_facet | Juan C. Vargas-Zambrano Mickael Arnaud Ana Antunes Khalil Karzazi Johanna Despres Regis Verdier Florence Boisnard Jerome Jund Cecile Janssen Didier Pinquier Denis Macina |
| author_sort | Juan C. Vargas-Zambrano |
| collection | DOAJ |
| description | Background: Assessing pertussis burden and the impact of the 2013 vaccination schedule update (3 + 1 to 2 + 1 schedule) in France is hindered by non-mandatory reporting. We aimed to estimate the cumulative incidence and hospitalization costs due to pertussis in France between 2008 and 2020. Methods: This observational retrospective cohort study was conducted using claims data from the French National Health Data System (SNDS) (January 2008–December 2020). Cumulative incidence of pertussis-hospitalizations, cumulative incidence ratios, and economic burden were analyzed. Cumulative incidences were estimated as the total pertussis-hospitalizations recorded annually from SNDS with respect to the French population, and expressed per 100,000 inhabitants. Cumulative incidence ratios were estimated using a negative binomial regression adjusted on the cyclical pattern of pertussis disease. Results: Overall, 10,893 patients were hospitalized for pertussis (severe cases: 36.7 % [n = 3997]; Bordetella pertussis disease: 93.3 % [n = 10,158]). Outbreaks were reported in 2009 (n = 1276), 2012–2013 (n = 2762), and 2017–2018 (n = 1727). The age group with the highest proportion of cases was 2–5 months (34.7 %), followed by 0–1 month (18.0 %) and ≥65 years (13.6 %). Cumulative incidence of hospitalization due to Bordetella pertussis disease was similar among infants aged <2 and 2–5 months (cumulative incidence ratio [CIR]=0.96 [0.90–1.02]; comparator: <2 months) and quite low in children aged ≥1 year (CIR≤0.01). Among adults, CIRs increased with age and peaked at ≥65 years (CIR=2.95 [2.57–3.38]; comparator: 18–25 years). CIRs decreased post schedule change (CIR=0.61 [0.43–0.84]; comparator: 3 + 1) and post-implementation of mandatory vaccination policy (CIR=0.68 [0.43–1.08]; comparator: before mandatory vaccination policy) across all age groups. Median overall costs were €3259 (all cases), with higher costs for severe cases and highest costs (€4880) for infants aged <2 months. Conclusion: Results reemphasized the persistent public health challenge of pertussis, especially in infants aged 0–5 months. Findings may guide future vaccination policies in Europe. |
| format | Article |
| id | doaj-art-eda69f4529124081bdccb1bd64978c1e |
| institution | Kabale University |
| issn | 1876-0341 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Infection and Public Health |
| spelling | doaj-art-eda69f4529124081bdccb1bd64978c1e2025-08-20T03:31:33ZengElsevierJournal of Infection and Public Health1876-03412025-08-0118810280110.1016/j.jiph.2025.102801Pertussis hospitalizations in France (2008–2020): A real-world retrospective analysis of incidence and costs based on the French National Health Data SystemJuan C. Vargas-Zambrano0Mickael Arnaud1Ana Antunes2Khalil Karzazi3Johanna Despres4Regis Verdier5Florence Boisnard6Jerome Jund7Cecile Janssen8Didier Pinquier9Denis Macina10Global Medical, Vaccines, Sanofi, Lyon, France; Correspondence to: 14 Espa. Henry Vallée, Lyon 69007, France.Real World Solutions, IQVIA, Bordeaux, FranceReal World Solutions, IQVIA, Lisbon, PortugalReal World Solutions, IQVIA, Paris, FranceReal World Solutions, IQVIA, Paris, FranceFrance Medical, Vaccines, Sanofi, Lyon, FranceGlobal Medical, Vaccines, Sanofi, Lyon, FranceService d’information et d’Evaluation médicale, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, FranceService d′Infectiologie, Centre Hospitalier Annecy Genevois, Epagny Metz-Tessy, FranceService de Pédiatrie Néonatale et Réanimation, University of Rouen Normandy, CHU Rouen, Hôpital Charles Nicolle, Rouen, FranceGlobal Medical, Vaccines, Sanofi, Lyon, FranceBackground: Assessing pertussis burden and the impact of the 2013 vaccination schedule update (3 + 1 to 2 + 1 schedule) in France is hindered by non-mandatory reporting. We aimed to estimate the cumulative incidence and hospitalization costs due to pertussis in France between 2008 and 2020. Methods: This observational retrospective cohort study was conducted using claims data from the French National Health Data System (SNDS) (January 2008–December 2020). Cumulative incidence of pertussis-hospitalizations, cumulative incidence ratios, and economic burden were analyzed. Cumulative incidences were estimated as the total pertussis-hospitalizations recorded annually from SNDS with respect to the French population, and expressed per 100,000 inhabitants. Cumulative incidence ratios were estimated using a negative binomial regression adjusted on the cyclical pattern of pertussis disease. Results: Overall, 10,893 patients were hospitalized for pertussis (severe cases: 36.7 % [n = 3997]; Bordetella pertussis disease: 93.3 % [n = 10,158]). Outbreaks were reported in 2009 (n = 1276), 2012–2013 (n = 2762), and 2017–2018 (n = 1727). The age group with the highest proportion of cases was 2–5 months (34.7 %), followed by 0–1 month (18.0 %) and ≥65 years (13.6 %). Cumulative incidence of hospitalization due to Bordetella pertussis disease was similar among infants aged <2 and 2–5 months (cumulative incidence ratio [CIR]=0.96 [0.90–1.02]; comparator: <2 months) and quite low in children aged ≥1 year (CIR≤0.01). Among adults, CIRs increased with age and peaked at ≥65 years (CIR=2.95 [2.57–3.38]; comparator: 18–25 years). CIRs decreased post schedule change (CIR=0.61 [0.43–0.84]; comparator: 3 + 1) and post-implementation of mandatory vaccination policy (CIR=0.68 [0.43–1.08]; comparator: before mandatory vaccination policy) across all age groups. Median overall costs were €3259 (all cases), with higher costs for severe cases and highest costs (€4880) for infants aged <2 months. Conclusion: Results reemphasized the persistent public health challenge of pertussis, especially in infants aged 0–5 months. Findings may guide future vaccination policies in Europe.http://www.sciencedirect.com/science/article/pii/S1876034125001509Cumulative incidenceFranceHospitalizationPertussisVaccination |
| spellingShingle | Juan C. Vargas-Zambrano Mickael Arnaud Ana Antunes Khalil Karzazi Johanna Despres Regis Verdier Florence Boisnard Jerome Jund Cecile Janssen Didier Pinquier Denis Macina Pertussis hospitalizations in France (2008–2020): A real-world retrospective analysis of incidence and costs based on the French National Health Data System Journal of Infection and Public Health Cumulative incidence France Hospitalization Pertussis Vaccination |
| title | Pertussis hospitalizations in France (2008–2020): A real-world retrospective analysis of incidence and costs based on the French National Health Data System |
| title_full | Pertussis hospitalizations in France (2008–2020): A real-world retrospective analysis of incidence and costs based on the French National Health Data System |
| title_fullStr | Pertussis hospitalizations in France (2008–2020): A real-world retrospective analysis of incidence and costs based on the French National Health Data System |
| title_full_unstemmed | Pertussis hospitalizations in France (2008–2020): A real-world retrospective analysis of incidence and costs based on the French National Health Data System |
| title_short | Pertussis hospitalizations in France (2008–2020): A real-world retrospective analysis of incidence and costs based on the French National Health Data System |
| title_sort | pertussis hospitalizations in france 2008 2020 a real world retrospective analysis of incidence and costs based on the french national health data system |
| topic | Cumulative incidence France Hospitalization Pertussis Vaccination |
| url | http://www.sciencedirect.com/science/article/pii/S1876034125001509 |
| work_keys_str_mv | AT juancvargaszambrano pertussishospitalizationsinfrance20082020arealworldretrospectiveanalysisofincidenceandcostsbasedonthefrenchnationalhealthdatasystem AT mickaelarnaud pertussishospitalizationsinfrance20082020arealworldretrospectiveanalysisofincidenceandcostsbasedonthefrenchnationalhealthdatasystem AT anaantunes pertussishospitalizationsinfrance20082020arealworldretrospectiveanalysisofincidenceandcostsbasedonthefrenchnationalhealthdatasystem AT khalilkarzazi pertussishospitalizationsinfrance20082020arealworldretrospectiveanalysisofincidenceandcostsbasedonthefrenchnationalhealthdatasystem AT johannadespres pertussishospitalizationsinfrance20082020arealworldretrospectiveanalysisofincidenceandcostsbasedonthefrenchnationalhealthdatasystem AT regisverdier pertussishospitalizationsinfrance20082020arealworldretrospectiveanalysisofincidenceandcostsbasedonthefrenchnationalhealthdatasystem AT florenceboisnard pertussishospitalizationsinfrance20082020arealworldretrospectiveanalysisofincidenceandcostsbasedonthefrenchnationalhealthdatasystem AT jeromejund pertussishospitalizationsinfrance20082020arealworldretrospectiveanalysisofincidenceandcostsbasedonthefrenchnationalhealthdatasystem AT cecilejanssen pertussishospitalizationsinfrance20082020arealworldretrospectiveanalysisofincidenceandcostsbasedonthefrenchnationalhealthdatasystem AT didierpinquier pertussishospitalizationsinfrance20082020arealworldretrospectiveanalysisofincidenceandcostsbasedonthefrenchnationalhealthdatasystem AT denismacina pertussishospitalizationsinfrance20082020arealworldretrospectiveanalysisofincidenceandcostsbasedonthefrenchnationalhealthdatasystem |